Tremeau Will Soon Test Rofecoxib In Phase III Hemophilia Joint Pain Trial
Drug Formerly Known As Vioxx Could Get New Lease On Life
Executive Summary
The company is developing the once-controversial drug formerly marketed as Vioxx under the name TRM-201 for hemophilia arthropathy with $110m in financing to support its program.